RHI Magnesita India Ltd.
RHI Magnesita
₹ 0.00
0.00 (0.00)%
NSE
BSE
Manufacturing
Small-cap - With a market cap of ₹95.90 Cr.
EX-Date | Purpose |
---|---|
11 06 2021 | Scheme of Arrangement Inter alia, to consider, inter alia, the following matters: 1) To take note of the order of the Hon ble National Company Law Tribunal, Mumbai Bench, Mumbai (“NCLT”) dated 5 May, 2021 sanctioning and approving the Composite Scheme of Amalgamation of RHI India Private Limited (“Transferor Company 1”), RHI Clasil Private Limited (“Transferor Company 2”) and Orient Refractories Limited (“Company”) and their respective shareholders and creditors (“Scheme”) as well as receipt by the Company of the certified copy of the order of the Hon ble NCLT sanctioning the Scheme and to also take note of the effective date of the Scheme as 7 June, 2021 i.e. date of receipt of the certified copy of the order of the Hon’ble NCLT. 2) To consider and approve the allotment ofshares of the Company to the equity shareholders of the Transferor Company 1 and the Transferor Company 2 in consideration of their amalgamation with the Company pursuant to and in the manner as approved in the Scheme as sanctioned by the Hon ble NCLT and to fix the record date for ascertaining the eligible shareholders of the Transferor Company 1 and Transferor Company 2 and to do all other things incidental and ancillary thereto, including filing of the application seeking listing and trading permission of the shares issued pursuant to Scheme. 3) To consider and approve change of name of the Company pursuant to and in accordance with the approved Scheme as sanctioned by the Hon ble NCLT |
25 06 2021 | Final Dividend & Audited Results |
11 08 2021 | Quarterly Results |
12 11 2021 | Quarterly Results |
10 02 2022 | Quarterly Results |
27 05 2022 | Final Dividend & Audited Results |
10 08 2022 | Quarterly Results |
09 11 2022 | Quarterly Results |
19 11 2022 | Preferential Issue of shares Inter alia, to consider the issue of equity shares of the Company by way of preferential allotment, in accordance with the applicable laws and shall be subject to such regulatory/ statutory approvals, as may be required, including the approval of the shareholders of the Company. Further, wthe Company proposes to seek Members? approval for the said proposal in due course by way of Postal Ballot/ Extraordinary General Meeting. |
04 01 2023 | Inter alia, to issue and allot 2,70,00,000 equity shares of the Company on preferential basis to DBRL. |
05 01 2023 | (Revised) The meeting of Board of Directors of the Company that wasscheduled to be held on Wednesday, 4 January 2023 is rescheduled due to unavoidable reasons/ circumstances andnow will take place on Thursday, 5 January 2023, inter alia, to issue and allot 2,70,00,000 equity shares of the Company on preferential basis to Dalmia Bharat Refractories Limited. |
13 02 2023 | Quarterly Results & Preferential Issue of shares & Inter alia, will also consider and approve raising further capital and to create, offer, issue and allot such number of equity shares, and/ or securities convertible into Equity Shares , and/ or securities linked to Equity Shares, and/ or any instrument or securities representing Equity Shares, and/ or convertible securities linked to Equity Shares (all of which are hereinafter collectively referred to as ?Securities?) or any combination of Securities, by way of qualified institutions placement, further public offering and/or combination thereof as may be considered appropriate or any other permissible mode, in one or more tranches, in accordance with the SEBI ICDR, as amended, and all other applicable laws, as may be considered appropriate, subject to shareholders approval and government/ regulatory/ statutory approvals and requirements, as applicable. |
01 04 2023 | Preferential Issue of shares & Inter alia to consider and approve the proposal for raising of funds by way of a preferential allotment by way of issue of equity shares to its promoters and / or the members of the promoter group of the Company for an aggregate amount not exceeding Rs. 2,000 million, in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and all other applicable laws, as may be considered appropriate, subject to the necessary government / regulatory / statutory approvals and requirements, as may be required including the approval of the shareholders of the Company |
30 05 2023 | Quarterly Results & Final Dividend & Audited Results |
10 08 2023 | Quarterly Results |
08 11 2023 | Quarterly Results |
13 02 2024 | Quarterly Results |
07 11 2024 | Quarterly Results |
11 02 2025 | Quarterly Results |
No News data available